1、 KWAA A, TALANA C, BLANKSON J N.Interferon alpha enhances NK cell function and the suppressive capacity of HIV-specific CD8(+) T cells[J].J Virol, 2019,93(3):e01541-18. KWAA A, TALANA C, BLANKSON J N.Interferon alpha enhances NK cell function and the suppressive capacity of HIV-specific CD8(+) T cells[J].J Virol, 2019,93(3):e01541-18.
2、 GILL U S, PEPPA D, MICCO L, et al. Interferon alpha induces sustained changes in NK cell responsiveness to hepatitis B viral load suppression in vivo[J].PLoS Pathog, 2016,12(8):e1005788. GILL U S, PEPPA D, MICCO L, et al. Interferon alpha induces sustained changes in NK cell responsiveness to hepatitis B viral load suppression in vivo[J].PLoS Pathog, 2016,12(8):e1005788.
3、 DATE I, KOYA T, SAKAMOTO T, et al. Interferon-alpha-induced dendritic cells generated with human platelet lysate exhibit elevated antigen presenting ability to cytotoxic T lymphocytes[J].Vaccines (Basel), 2020,9(1):10. DATE I, KOYA T, SAKAMOTO T, et al. Interferon-alpha-induced dendritic cells generated with human platelet lysate exhibit elevated antigen presenting ability to cytotoxic T lymphocytes[J].Vaccines (Basel), 2020,9(1):10.
4、 崔智亮, 张俊, 叶锦玲, 等.儿童疱疹性咽峡炎采用不同治疗方法的对比研究[J].广州医药, 2019,50(5):6-9. 崔智亮, 张俊, 叶锦玲, 等.儿童疱疹性咽峡炎采用不同治疗方法的对比研究[J].广州医药, 2019,50(5):6-9.
5、 曹甦, 姚惠辉, 牛锋.重组人干扰素α-1b雾化治疗婴幼儿疱疹性咽峡炎的临床效果[J].中国医药导报, 2019,16(20):156-158. 曹甦, 姚惠辉, 牛锋.重组人干扰素α-1b雾化治疗婴幼儿疱疹性咽峡炎的临床效果[J].中国医药导报, 2019,16(20):156-158.
6、 贺锦华, 赵小红, 马利维.118例疱疹性咽峡炎患儿心肌损伤临床分析[J].检验医学与临床, 2012(19):2442-2443. 贺锦华, 赵小红, 马利维.118例疱疹性咽峡炎患儿心肌损伤临床分析[J].检验医学与临床, 2012(19):2442-2443.
7、 陈全景, 王春晖.疱疹性咽峡炎患儿心肌酶检测临床评价[J].山东医药, 2007(19):149-150. 陈全景, 王春晖.疱疹性咽峡炎患儿心肌酶检测临床评价[J].山东医药, 2007(19):149-150.
8、 钱招昕,黄寒,林晓娟.川芎嗪对柯萨奇B3病毒感染乳鼠心肌细胞的保护作用及信号转导机制研究[J].中国当代儿科杂志, 2009,11(8):687-690. 钱招昕,黄寒,林晓娟.川芎嗪对柯萨奇B3病毒感染乳鼠心肌细胞的保护作用及信号转导机制研究[J].中国当代儿科杂志, 2009,11(8):687-690.
9、 WU Z, PENG H, DU Q, et al. GYY4137, a hydrogen sulfidereleasing molecule, inhibits the inflammatory response by suppressing the activation of nuclear factorkappa B and mitogenactivated protein kinases in Coxsackie virus B3 infected rat cardiomyocytes[J].Mol Med Rep, 2015,11(3):1837-1844. WU Z, PENG H, DU Q, et al. GYY4137, a hydrogen sulfidereleasing molecule, inhibits the inflammatory response by suppressing the activation of nuclear factorkappa B and mitogenactivated protein kinases in Coxsackie virus B3 infected rat cardiomyocytes[J].Mol Med Rep, 2015,11(3):1837-1844.
10、 BECK M A.Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency[J].J Nutr, 1997,127(5 Suppl):966S-970S. BECK M A.Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency[J].J Nutr, 1997,127(5 Suppl):966S-970S.
11、 朱经林,刘井秀,刘小花,等.小儿疱疹性咽峡炎血常规特点及其临床意义[J].现代医院,2020,20(3):463-465. 朱经林,刘井秀,刘小花,等.小儿疱疹性咽峡炎血常规特点及其临床意义[J].现代医院,2020,20(3):463-465.
12、 YE Y Z, DOU Y L, HAO J H, et al. Efficacy and safety of interferon alpha-2b spray for herpangina in children: A randomized, controlled trial[J].Int J Infect Dis, 2021(107):62-68. YE Y Z, DOU Y L, HAO J H, et al. Efficacy and safety of interferon alpha-2b spray for herpangina in children: A randomized, controlled trial[J].Int J Infect Dis, 2021(107):62-68.
13、 TAKECHI M, FUKUSHIMA W, NAKANO T, et al.Nationwide survey of pediatric inpatients with hand, foot, and mouth disease, herpangina, and associated complications during an epidemic period in Japan: estimated number of hospitalized patients and factors associated with severe cases[J].J Epidemiol, 2019,29(9):354-362. TAKECHI M, FUKUSHIMA W, NAKANO T, et al.Nationwide survey of pediatric inpatients with hand, foot, and mouth disease, herpangina, and associated complications during an epidemic period in Japan: estimated number of hospitalized patients and factors associated with severe cases[J].J Epidemiol, 2019,29(9):354-362.
14、 中华医学会儿科学分会感染学组, 国家感染性疾病医疗质量控制中心.疱疹性咽峡炎诊断及治疗专家共识(2019年版)[J].中华儿科杂志, 2019,57(3):177-180. 中华医学会儿科学分会感染学组, 国家感染性疾病医疗质量控制中心.疱疹性咽峡炎诊断及治疗专家共识(2019年版)[J].中华儿科杂志, 2019,57(3):177-180.
